GHRL and Alzheimer disease: Four months of treatment with palm11-PrRP31 (p = 0.03) and Dpr3-ghrelin (p = 0.02) significantly reduced microgliosis in the hippocampi of 3xTg-AD mice, but the effect of liraglutide was not significant (Fig. 4.P).